Table 3.

Ongoing and pending unpublished hematopoietic lineage trials.

ClinicalTrials.gov Identifier	Study type	Cell type	Planned enrollment	Timing of delivery	Delivery route	Status
NCT01518231 “AHSCTIS” China	Phase I Randomized Open-label	CD34+ from peripheral blood	40	<12 months	IA	Recruiting/unknown
NCT00473057 Brazil	Phase I Non-Randomized Open-label	Autologous BM-MNC	12	<90 days	IA or IV	Completed 2011, no publications to date
NCT01832428 “BMACS” India	Phase I/II Non-Randomized Open-label	BM-MNC	50	Chronic	IT	Not currently recruiting/unknown
NCT02290483 also identified by NCT02178657 Spain	Phase II Randomized Open-label	BM-MNC (2 × 106 or 5 × 106 cells/kg)	76	<7 days	IA	Recruiting/paper published on miRNAs from the trial but no study results to date
NCT02795052 “NEST” USA	Phase n/a Non-Randomized Open-label	Autologous BMSC (intranasal for hypothesized blood-brain barrier penetration)	300	>6 months	IV or intranasal	Recruiting